LIG Audit Status
This page is public. The editing interface lives at /cgi-bin/audit.cgi and requires login. Full-text AI processing status is at /cgi-bin/fulltext-status.cgi; paper upload is at /cgi-bin/fulltext-upload.cgi.
Batch audit-20260421-labels-seed42 · created 2026-04-21 07:03 · seed 42
caucasian
25 reviewed / 25 total
0 pending
Confirmed caucasian 25 · Not caucasian on review 0
white
25 reviewed / 25 total
0 pending
Confirmed white 24 · Not white on review 1
european
10 reviewed / 25 total
15 pending
Confirmed european 10 · Not european on review 0
other
25 reviewed / 25 total
0 pending
Confirmed other 25 · Not other on review 0
none of these labels
0 reviewed / 100 total
100 pending
Confirmed none of these labels 0 · Uses tracked labels on review 0
["Ethnic variation of <i>IL‐4</i> intron 3 VNTR gene polymorphism; its association with type 2 diabetes mellitus and its complication (neuropathy) in Egyptian subjects"]
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2018 · article 60989976 · 10.1002/ajmg.b.32647
Review target: other. Review status: reviewed
Audit result: confirmed other · reviewer georgina · 2026-05-26 21:42
Classifier flags: other: Egyptian; Ethnic variation
<jats:p>Type 2 diabetes mellitus (T2DM) has multigenetic and environmental interactive factors. Although diabetic neuropathies (DPN) are the most common, but at the same time, the least recognized and understood long‐term complication of diabetes. This study aimed to investigate the association of <jats:italic>IL‐4</jats:italic> VNTR gene polymorphism with T2DM complicated with neuropathy in Egyptian subjects. This is a case control study including 102 T2DM Egyptian patients, plus 188 unrelated healthy individuals as controls. They were evaluated for variable number tandem repeat (VNTR); 70 base pair repeats located in the intron 3; of <jats:italic>IL‐4</jats:italic> gene using the PCR technique. Homozygote frequency of the three‐repeat allele (A1/A1) genotype of <jats:italic>IL‐4 VNTR</jats:italic> was nearly equal among diabetic cases and controls (60.8% vs. 62.2%, respectively). Heterozygous frequency of (A1/A2) genotype was higher among controls compared to cases (33.5% vs. 19.6%, respectively) but not statistically significant. The (A2) allele had a significantly higher frequency in diabetic cases compared to controls (29.3% vs. 21.0%, respectively) while the (A1) allele had lower frequency but not significant one (70.7% vs. 79.0%, respectively). Comparing cases complicated with diabetic neuropathy vs. noncomplicated cases regarding their polymorphic IL‐4 (VNTR) genotypes revealed a nonsignificant lower frequency of (A1A1) genotype (57.1% vs. 65.1%, respectively, <jats:italic>p</jats:italic> = .57) with a higher combined (A2A2 + A1/A2) genotype frequency (42.9% vs. 34.9%, respectively). Only two haplotypes (A1) & (A2) of <jats:italic>IL‐4</jats:italic> (VNTR) gene were recognized among Egyptian population; (A2) allele may influence in diabetes but not its complication (neuropathy) among Egyptian diabetic patients.</jats:p>